Search Results 611-620 of 17470 for PID Treatment

  1. Endometrial cancer - Doctors and departments - Mayo Clinic

    Learn about the symptoms and causes of this cancer of the uterus. Treatments include hysterectomy, radiation therapy, and chemotherapy and other medicines.

  2. infertility Archives - Mayo Clinic News Network

    ... treatment on fertility? Watch: The Mayo Clinic ... uterus. Causes of fallopian tube damage or blockage can include: Pelvic inflammatory disease, an infection of ...

  3. Polycystic kidney disease - Doctors and departments - Mayo Clinic

    ... treatment option for people who have PKD with liver involvement. These medicines are now in clinical trials, and tolvaptan is approved for use in some ...

  4. Peripheral neuropathy - Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and scientists are studying new ways to diagnose and treat neuropathies, including peripheral neuropathy. Publications. See a list ...

  5. Hairy cell leukemia - Symptoms and causes - Mayo Clinic

    This slow-growing cancer doesn't always need immediate treatment. When hairy cell leukemia treatment is needed, it usually starts with chemotherapy.

  6. Tricuspid valve disease - Doctors and departments - Mayo Clinic

    This condition affects the valve between the two right heart chambers. It changes how blood flows through the heart. Learn the symptoms and treatment.

  7. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

    Paclitaxel and carboplatin are chemotherapy drugs used as part of the usual treatment approach for this type of cancer. This study aims to assess if adding ...

  8. Oncology (Medical) - Clinical trials

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  9. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

    Part 1 is a dose escalation phase to determine the maximum tolerated dose (MTD) of INCB040093, a PI3Kδ inhibitor, or a tolerated, pharmacologically active dose; ...

  10. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    ... treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials ...